SchwartzbergL., BroderM.S., AilawadhiS., et al.Impact of early detection on cancer curability: A modified Delphi panel study. PLOS ONE, 17(12): e0279227 (2022).
3.
HackshawA., CohenS.S., ReichertH., et al.Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. British Journal of Cancer, 125:1432–1442 (2021).
4.
CohenJ.D., LiL., WangY., et al.Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science, 359(6378):926–930 (2018).
5.
HasenleithnerS.O., SpeicherM.R.How to detect cancer early using cell-free DNA. Cancer Cell, 40:1464–1466 (2022).
6.
MoserT., KühbergerS., LazzeriI., et al.Bridging biological cfDNA and machine learning approaches. Trends in Genetics DOI:10.1016/j.tig.2023.01.004 (2023).
7.
HasenleithnerS.O., SpeicherM.R.A clinician's handbook for using ctDNA throughout the patient journey. Molecular Cancer, 21:81 (2022).
TaylorM.S., WuC., FridyP.C., et al.Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker. bioRxiv DOI:10.1101/2023.01.25.525462 (2023).
